Orilotimod Potassium
potassium;(2R)-2-amino-5-[[(1R)-1-carboxylato-2-(1H-indol-3-yl)ethyl]amino]-5-oxopentanoate;hydron
Molecular Identity
Orilotimod Potassium
potassium;(2R)-2-amino-5-[[(1R)-1-carboxylato-2-(1H-indol-3-yl)ethyl]amino]-5-oxopentanoate;hydron
PubChem CID: 76318569
2D Structure
Properties
C16H18KN3O5
Molecular Formula
371.43
Molecular Weight
g/mol
371.0884
Exact Mass
Da
151
TPSA
May have limited oral absorption
4
H-Bond Donors
6
H-Bond Acceptors
473
Complexity
SMILES
Canonical SMILES
SMILES: [H+].C1=CC=C2C(=C1)C(=CN2)CC(C(=O)[O-])NC(=O)CCC(C(=O)[O-])N.[K+]Isomeric SMILES
SMILES: [H+].C1=CC=C2C(=C1)C(=CN2)C[C@H](C(=O)[O-])NC(=O)CC[C@H](C(=O)[O-])N.[K+]Synonyms(13)
Orilotimod potassiumAPO805K1APO-805K1Orilotimod potassium [USAN]Q8858ZSK4YUNII-Q8858ZSK4YD-Tryptophan, D-gamma-glutamyl-, potassium salt (1:1)Orilotimod potassium (USAN)D-TRYPTOPHAN, D-.GAMMA.-GLUTAMYL-, POTASSIUM SALT (1:1)RefChem:168514960155-19-5CHEMBL3137328SCHEMBL29439011
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Orilotimod Potassium
Loading drug network...